Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL8741925 | 0.82 | CTSS (0.33) | — | |
| SCHEMBL27692277 | 0.81 | CNR2 (0.31) | CNR2 | |
| SCHEMBL28168000 | 0.76 | CNR2 (0.32) | CNR2 | |
| SCHEMBL9333241 | 0.72 | CNR2 (0.33) | CNR2 | |
| SCHEMBL2190101 | 0.72 | PIK3CD (0.30) | — | |
| SCHEMBL25188479 | 0.69 | MMP1 (0.36) | CNR2 | |
| SCHEMBL18492971 | 0.68 | — | — | |
| SCHEMBL10635153 | 0.67 | DPP4 (0.32) | — | |
| SCHEMBL892802 | 0.67 | — | — | |
| SCHEMBL1432498 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234517-A | Bicyclic peptide ligand drug conjugates | 拜斯科阿迪有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118215505-A | Bicyclic peptide ligand drug conjugates | 拜斯科技术开发有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-104640842-B | Aplysiatoxin-10 derivant, its preparation method and comprise its anticancer pharmaceutical composition | CELLTRION INC. (KR) | 2016-11-30 | — | — | CN | claimed |
| CN-104640842-A | Dolastatin-10 derivative, method of producing same and anticancer drug composition containing same | CELLTRION INC | 2015-05-20 | — | — | CN | claimed |
| CN-118234517-A | Bicyclic peptide ligand drug conjugates | 拜斯科阿迪有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118215505-A | Bicyclic peptide ligand drug conjugates | 拜斯科技术开发有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-112004826-B | Reverse agonistic anti-US 28 antibodies | 自由大学基金会 | 2024-06-14 | — | — | CN | disclosed |
| CN-113121639-B | Aureostatin analogue and conjugate thereof, preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117255790-A | Chemical coupling connector and application thereof | 四川科伦博泰生物医药股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-116137818-A | Para-amino-benzyl linkers, methods of making and use thereof in conjugates | 法国施维雅药厂 | 2023-05-19 | — | — | CN | disclosed |
| CN-116115771-A | Materials and methods relating to linkers for use in protein drug conjugates | 伊科思达医疗有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-115698079-A | anti-CD 79B antibody drug conjugate, preparation method and medical application thereof | 上海拓界生物医药科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-113121639-A | Auristatin analogue and conjugate thereof, preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-112004826-A | Reverse agonistic anti-US 28 antibodies | 自由大学基金会 | 2020-11-27 | — | — | CN | disclosed |
| CN-109475567-A | Silanol-based therapeutic payloads | 布兰克生物股份有限公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-108778274-A | With the chemotherapeutant targets neoplastic cells of coupling part and anti-protein lyase antibody conjugate by that can crack in vivo | 新泽西鲁特格斯州立大学 | 2018-11-09 | — | — | CN | disclosed |
| CN-107073133-A | Materials and methods relating to linkers for use in protein drug conjugates | 吉利斯拉有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-104640842-B | Aplysiatoxin-10 derivant, its preparation method and comprise its anticancer pharmaceutical composition | CELLTRION INC. (KR) | 2016-11-30 | — | — | CN | disclosed |
| CN-104640842-A | Dolastatin-10 derivative, method of producing same and anticancer drug composition containing same | CELLTRION INC | 2015-05-20 | — | — | CN | disclosed |